Botanix Pharmaceuticals
Australia - West PerthPharmaceutical
Focus: Botanix Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel synthetic cannabinoid therapeutics for dermatology and antimicrobial indications. The company is headquartered in Perth, Australia and operates a focused pipeline centered on dermatological and infectious disease applications.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Botanix Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Botanix Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Growing
Growth14.0yr
Only marketed product providing commercial revenue stream with 17-year exclusivity runway; recently approved NDA supporting company cash runway.
Help build intelligence for Botanix Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.